A review of the current state in neointimal hyperplasia development following endovascular intervention and minor emphasis on new horizons in immunotherapy-Reference-Cited by-同舟云学术

A review of the current state in neointimal hyperplasia development following endovascular intervention and minor emphasis on new horizons in immunotherapy

Published:2023 Issue:4 Volume:31 Page:191
ISSN:2289-0882
Container-title:Translational and Clinical Pharmacology
language:en
Short-container-title:Transl Clin Pharmacol

Author:

Dinc Rasit¹^ORCID

Affiliation:

1. INVAMED Medical Innovation Institute, Ankara 06810, Turkey.

Publisher

XMLink

Subject

Pharmacology (medical)

Link

https://tcpharm.org/pdf/10.12793/tcp.2023.31.e18

Reference57 articles.

1. Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis

2. Cost and inpatient burden of peripheral artery disease: Findings from the National Inpatient Sample

3. Lower Extremity Peripheral Artery Disease: Contemporary Epidemiology, Management Gaps, and Future Directions: A Scientific Statement From the American Heart Association

4. 2016 AHA/ACC Guideline on the Management of Patients with Lower Extremity Peripheral Artery Disease: Executive Summary

5. Distinct profiles of immune cell populations underlie in-stent restenosis: a cluster analysis approach

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Early thrombus formation is required for eccentric and heterogeneous neointimal hyperplasia under disturbed flow;Journal of Thrombosis and Haemostasis;2024-08

2. Role of Neutrophils as Therapeutic Targets in Intracerebral Hemorrhage;Therapeutic Innovation & Regulatory Science;2024-05-16

3. Identification of the Neointimal Hyperplasia-Related LncRNA-mRNA-Immune Cell Regulatory Network in a Rat Carotid Artery Balloon Injury Model;International Heart Journal;2024